首页> 外文期刊>Urology >Utility of preoperative renal artery embolization for management of renal tumors with inferior vena caval thrombi.
【24h】

Utility of preoperative renal artery embolization for management of renal tumors with inferior vena caval thrombi.

机译:术前肾动脉栓塞术用于治疗下腔静脉血栓形成的肾肿瘤。

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVES: To review our experience with radical nephrectomy and inferior vena cava thrombectomy (RNIVCT) to determine the utility of preoperative embolization. Preoperative embolization has been used as an adjunctive procedure to facilitate surgical resection of complex renal tumors. METHODS: From 1990 to 2007, 225 patients with renal tumors and inferior vena cava thrombus underwent RNIVCT, including 135 patients who had undergone preoperative renal artery embolization and 90 patients who had not. The effect of embolization on perioperative morbidity and mortality, transfusion requirements, blood loss, and operative time was analyzed by comparing the 2 groups. RESULTS: The mean primary tumor size was similar in both groups; however, 67% of the RNIVCT embolization group vs 48% of the nonembolization group had retrohepatic (level III) or supradiaphragmatic (level IV) thrombus extension (P = .032). The RNIVCT embolization patients had a greater median number of perioperative units transfused (8 vs 4; P = .001), a longer operative time (390 vs 313 minutes; P < .001), more postoperative complications (43% vs 29%; P < .001), a longer intensive care unit stay (2 vs 0.5 days), and increased perioperative mortality (13% vs 3%; P = .017). No differences were found in intraoperative complications or length of hospitalization. Multivariate analysis showed a fivefold greater risk of perioperative death (adjusted odds ratio 5.5; P = .029) and a trend toward increased blood transfusion (regression coefficient 3.9; P = .08) with preoperative embolization. CONCLUSIONS: The results of our study have shown that routine preoperative renal artery embolization in patients undergoing RNIVCT does not provide any measurable benefit in reducing blood loss or complications and was associated with increased major perioperative complications and mortality.
机译:目的:回顾我们在根治性肾切除术和下腔静脉血栓切除术(RNIVCT)中的经验,以确定术前栓塞的实用性。术前栓塞术已被用作辅助手术,以促进复杂肾脏肿瘤的手术切除。方法:从1990年至2007年,对225例肾肿瘤和下腔静脉血栓患者进行了RNIVCT,其中135例接受了术前肾动脉栓塞手术的患者和90例未进行过肾动脉栓塞术的患者。通过比较两组栓塞对围手术期发病率和死亡率,输血需求,失血量和手术时间的影响。结果:两组的平均原发肿瘤大小相似。然而,RNIVCT栓塞组的67%与非栓塞组的48%具有肝后(III级)或radi上(IV级)血栓扩展(P = .032)。 RNIVCT栓塞患者的围手术期输注术中位数更高(8 vs 4; P = .001),手术时间更长(390 vs 313分钟; P <.001),术后并发症更多(43%vs 29%; P <0.001)。 P <.001),重症监护病房住院时间更长(2天vs 0.5天),围手术期死亡率增加(13%vs 3%; P = .017)。术中并发症或住院时间无差异。多因素分析显示,术前栓塞使围手术期死亡的风险增加了五倍(调整后的优势比为5.5; P = .029),并且有增加的输血趋势(回归系数3.9; P = .08)。结论:我们的研究结果表明,接受RNIVCT的患者在术前常规进行肾动脉栓塞术对减少失血或并发症没有任何可衡量的益处,并且与围手术期并发症和死亡率增加有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号